Clayton Boldt, Ph.D.
2.8K posts
Clayton Boldt, Ph.D.
@claytonboldt
Recovered 🧬 Ph.D. ➡️ PR and comms @MDAndersonNews. Just trying to spread a little 🔬science love. Tweets are my own.
Houston, TX Katılım Mart 2010
390 Takip Edilen630 Takipçiler
Parents of toddlers: What are your favorite shoes for your kiddos?
English
Clayton Boldt, Ph.D. retweetledi
Stop by #ASCO24 Booth 13069 to meet our experts and learn about training and career opportunities at MD Anderson.
Find the full schedule at MDAnderson.org/ASCO. @ASCO #EndCancer
English
Clayton Boldt, Ph.D. retweetledi
“Working in the lab is really where I felt at home,” says our Dr. Kenneth Hu, a researcher studying tumor cell interactions to advance immunotherapy.
Here, he shares why MD Anderson is the perfect place to do that: brnw.ch/21wKe0q #Immunology #EndCancer
English
Clayton Boldt, Ph.D. retweetledi
Our teams @MDAndersonNews are grateful to the Belfer family for their forward-thinking vision and for their renewed investment in the Belfer Neurodegeneration Consortium. Their generosity has and will continue to impact countless lives. #EndCancer
UT MD Anderson@UTMDAnderson
We’re grateful for the Belfer family’s generous $20 million gift to advance neurodegeneration research through the Belfer Neurodegeneration Consortium. Read how this gift helps further our mission to #EndCancer: bit.ly/3y9aO8T @ppisters @JimRayNDC
English
Clayton Boldt, Ph.D. retweetledi
Selfless service.
Loved spreading the spirit of the #12thMan, making memories with the children at @MDAndersonNews and passing out gifts of iPads, 12th Man towels and hats.
#EndCancer #GigEm
English
Clayton Boldt, Ph.D. retweetledi
Amazing leadership lessons on and off the court with tennis legends @ChrissieEvert and @Martina. Thank you for sharing your journey with us. @MDAndersonNews #endcancer
English
Clayton Boldt, Ph.D. retweetledi
Congratulations to our Dr. Sharon Dent on her election to @theNASciences for her contributions to chromatin research, which have furthered our understanding of cancer mutations. She joins eight previously elected researchers from MD Anderson. bit.ly/3WrKFft @ppisters @DraettaG #EndCancer
English
Clayton Boldt, Ph.D. retweetledi
Children receiving cancer treatment at MD Anderson treated to special prom party palooza @TroyKlessTV @MDAndersonNews khou.com/article/life/h…
English
Clayton Boldt, Ph.D. retweetledi
Reflection on an extraordinary day celebrating RUSH MD Anderson Cancer Center across the region — two stellar organizations with world-class teams working together to #EndCancer and save more lives. @MDAndersonNews @RushMedical
UT MD Anderson@UTMDAnderson
Today, we welcomed @RushMedical as our seventh MD Anderson Cancer Network partner, bringing more people greater access to advanced cancer care and clinical trials. RUSH MD Anderson Cancer Center patients will be able to access care in locations across Chicago, the Chicago suburbs and Northwest Indiana. #EndCancer" target="_blank" rel="nofollow noopener">mdanderson.org/newsroom/md-an…
English
Clayton Boldt, Ph.D. retweetledi
Our Chief Patient Experience Officer Dr. Michael Frumovitz is committed to making sure patients, their families and staff members feel heard, valued and empowered at MD Anderson. He has been named one of the 2024 top chief experience officers to know by @BeckersHR. bit.ly/3JUifDD @Frumovitz #EndCancer
English
Clayton Boldt, Ph.D. retweetledi
MD Anderson and CureVac announce a strategic collaboration to develop off-the-shelf mRNA-based cancer vaccines for select hematologic and solid tumors.
Read about it here: brnw.ch/21wIRth @CureVacRNA #EndCancer
English
Clayton Boldt, Ph.D. retweetledi
Thank you to everyone who stopped by our booth at #AACR24 to discuss the latest cancer research advances. We hope to see you all again next year. #EndCancer
English
Clayton Boldt, Ph.D. retweetledi
"If exercise and food are medicine, how can we as a society and as health care systems get patients to take this?" says our Dr. Karen Basen-Engquist of improving health behavior practices in cancer survivors.brnw.ch/21wIFt8 @AACR @K_BasenEngquist #AACR24 #EndCancer
English
Clayton Boldt, Ph.D. retweetledi
There’s still time to meet our experts today at #AACR24.
See the schedule: MDAnderson.org/AACR
@AACR #EndCancer
English
Clayton Boldt, Ph.D. retweetledi
The first-in-class PARP1-selective inhibitor saruparib demonstrates early efficacy and an improved safety profile in breast cancers with DNA repair defects.
See the findings presented by our Dr. Timothy Yap (CT014): bit.ly/43SfsE7 @AACR #AACR24 #BSCM #EndCancer
English
Clayton Boldt, Ph.D. retweetledi
Happening now at #AACR24: Dr. Scott Kopetz, @AACR Waun Ki Hong Award recipient, is giving a lecture on Adaptive Resistance in BRAF- and KRAS-mutated #ColorectalCancer. @skopetz #EndCancer
English
Clayton Boldt, Ph.D. retweetledi
We congratulate the recipient of the AACR-Waun Ki Hong Award for Outstanding Achievement in Translational and Clinical Cancer Research, Scott Kopetz, MD, PhD.
Dr. Kopetz will present his Award Lecture at #AACR24 on Sunday April 7, 4:30-5:15 PM. Learn more: bit.ly/49qft38
English
English
@dheady8 See ya there! Won’t be in the press room sadly, but I’ll be around!
English
Looking forward to attending #AACR24! So much great research from @UCLAHealth investigators being highlighted at the meeting.
English